| 000 | 00595nam a2200217Ia 4500 | ||
|---|---|---|---|
| 005 | 20260808125441.0 | ||
| 008 | 260808s9999||||xx |||||||||||||| ||und|| | ||
| 020 | _a0-89970-160-4 | ||
| 035 | _a5134 | ||
| 041 | _aENG | ||
| 082 | _a615.2 | ||
| 100 | _aAmerican Medical Association | ||
| 245 | 0 | _aAMA drug evaluation | |
| 250 | _a5th | ||
| 260 |
_aPhiladelphia _bW. B. Saunders Company _c1983 |
||
| 300 | _axxii + 1884 | ||
| 500 | _a15152 / 28.06.1984 | ||
| 505 | _achemistry, pharmaceutical chemistry, drug substances | ||
| 650 |
_aChemistry _bPharmacology -- Therapeutics |
||
| 942 | _cBK | ||
| 999 |
_c5132 _d5132 |
||